Bassam Atallah, PharmD

Associate Dean for Clinical Affairs - Dubai Medical University - College of Pharmacy

[Bassam Atallah, PharmD @batallah08]

Beyond SGLT2: The Emerging Role of Dual SGLT1/2 Inhibition in Heart Failure https://t.co/yLLXspnuid via @MedscapeCME

[ACCP Cardiology PRN @accpcardprn]

An exciting new trial for #WNW - COBRRA compared apixaban vs rivaroxaban for VTE treatment and found a significantly decreased risk of bleeding associated with apixaban use (3.3% vs 7.1%); this RCT backs up the trend seen in retrospective data!

https://t.co/vJlquRGdIV

[Stephen English MD, MBA @SWEnglishMD]

Not noninferior = INFERIOR

Take your blood thinners folks - still the gold standard for stroke prevention in patients with AF who don’t have clear contraindication to anticoagulation.

[Bassam Atallah, PharmD @batallah08]

https://t.co/oDlt9YsnIq

[ECS_heart @ECS_heart]

A messege from Dr Bassam Atallah:
"On #WorldPharmacistsDay, we recognize the crucial role pharmacists play in advancing safe, effective, and evidence-based cardiac care.

Thank you for your dedication to patients’ health."
#EmiratesCardiacSociety

#ECS @batallah08

[American College of Cardiology @ACCinTouch]

ACC’s #FamilialHypercholesterolemia online course will keep you up to date on the latest tools & techniques to recognize HoFH & HeFH – a life-changing diagnosis that provides access to early treatment options. More ➡️ https://t.co/bPzupFYxpz

#ACCEd #CholesterolEducationMonth

[American College of Cardiology @ACCinTouch]

ICYMI: A new ACC/AHA Scientific Statement introduces the PREVENT risk calculator & details the supporting evidence & rationale behind its use.

Learn more: https://t.co/bZe8izHiZB #hypertension @JACCJournals

[Bassam Atallah, PharmD @batallah08]

https://t.co/jjNHbtdcCX #AHA25

[Adrian da Silva @adrianjdasilva]

New in JACC HF:

#Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in #HFpEF

https://t.co/6q5JJWlrHq

[JACC Journals @JACCJournals]

🫀 In familial hypercholesterolemia (HeFH), artery changes start young—carotid plaque at 17♂ / 30♀, coronary plaque at 26♂ / 36♀. Triple checks 🩻 (carotid, coronary, CAC) improve risk stratification & prevention 💪 Full study 👉 https://t.co/jAZ4YqB6hn #JACCAsia #cvPrev

[JAMA Cardiology @JAMACardio]

Finerenone reduced the need for loop diuretic dose intensification and lowered the average loop diuretic dose across all diuretic subgroups in patients with HFmrEF/HFpEF.

https://t.co/7ivf3aYVZ7

[JAMA Cardiology @JAMACardio]

AFIRE RCT: Rivaroxaban monotherapy yielded a consistent net clinical benefit across all age groups, especially in older patients with atrial fibrillation and stable coronary artery disease. https://t.co/0uhqutYDvn

[JACC Journals @JACCJournals]

In frail, elderly #AFib patients previously on a vitamin K antagonist, switching to standard-dose direct-acting oral anticoagulant reduced stroke, fatal/intracranial bleeding, and death, despite more GI bleeding. https://t.co/VueCCDedLL #JACC #DOAC

[Rob DiDomenico @robdeedo]

Kudos to @mfiuzat, @batallah08, Robert Page & Orly Vardeny for shedding light on the training, practice, & roles of HF pharmacists. https://t.co/7U9mOuzUVQ

[ISCP / International Society of CV Pharmacotherapy @ISCPcardio]

🎤 Meet Dr. Bassam Atallah – Our Featured Speaker
Join Dr. Atallah (UAE) on July 23 as he walks us through pharmacologic innovations in HCM care—from classic medications to emerging myosin inhibitors.

With a decade of clinical and academic experience, Dr. Atallah brings a practical, evidence-based perspective.

📅 Don’t miss this live global session!
🔗 Free registration open now:
https://t.co/4nkNPBpYIU

#ISCP2025 #CardioPharma #HeartHealth #MedicalWebinar

@doreen_sy
@ALorenzatti
@PabloAvanzas
@amartinezrubio
@KojiHasegawa6
@jckaski
@kjfilipiak
@beaverspharmd
@KarleziAlonso
@VebionaBachtar
@DanielPiskorz
@DrPontecarlosi
@santon74
@kit6750
@kfranco_c
@JD_Bennetts
@Risantilopezcar
@jacktanwc

[Bassam Atallah, PharmD @batallah08]

The Current Landscape of Training, Practice, and Roles of Pharmacists ... https://t.co/nJBaYxZcDP

[Bassam Atallah, PharmD @batallah08]

Grateful for 10 years @CCAD !

[NEJM @NEJM]

Original Article: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism (API-CAT) https://t.co/dwlW8g5bkS

Editorial: Cancer-Associated Venous Thromboembolism — Beyond 6 Months https://t.co/awZitdKfYb

#Cardiology

[ACCP @ACCP]

Congratulations to ACCP member Bassam Atallah and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: https://t.co/ytGNjUPHHt

@JACCPJournal #OpenAccess #MakingAnImpact #ACCP

[Bassam Atallah, PharmD @batallah08]

Screening and treatment of iron deficiency among heart failure patients with impaired ejection fraction: The impact of a pharmacist‐led protocol - Alaryani - JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY - Wiley Online Library https://t.co/LjAhDmSA45